Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma
1 clinical trials · Condition
◉ Watch Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma (NCT01979536) | National Cancer Institute (NCI) | 2013-11-13 |
Track Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.